Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer (Q73764054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

F Saint

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J J Patard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Irani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Salomon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Hoznek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Legrand

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Debois

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C C Abbou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D K Chopin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

617-21; discussion 621-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900921-9

7 January 2021

10.1016/S0090-4295(01)00921-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306359%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference